Both in Pharmaceuticals
Atossa Therapeutics vs Edesa Biotech
Over the past year ATOS returned −83.7% and EDSA returned +38.2%; their daily moves had a correlation of 0.04.
ATOS −83.7% EDSA +38.2%Growth of $1, one year, split-adjusted
| Metric | ATOS | EDSA |
|---|---|---|
| Price | $2.17 | $2.57 |
| Market cap | $21.7M | $24.8M |
| Today | −2.69% | −4.81% |
| 1 month | −4.4% | −35.9% |
| 6 months | −59.3% | −85.4% |
| Year to date | −75.5% | +81.0% |
| 1 year | −83.5% | +24.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $26.1M | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 89.1% |
| Short % of float | 7.7% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).